Roto-Gro International Limited secures purchase order

|

Published 29-MAR-2019 10:08 A.M.

|

2 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.


Click Here to View Latest Articles

Roto-Gro International’s (ASX:RGI) wholly-owned subsidiary, Global Fertigation Solutions Inc. (GFS), has secured a purchase order from TGIG LLC (trading as The Grove) for approximately A$220,000.

Global Fertigation Solutions provides an automated, precise, real-time batching and dosing of bespoke nutrient recipes for delivery in agricultural applications throughout their life span.

The intuitive fertigation system removes salts, heavy minerals and contaminants from municipal water, creating an equalised and homogeneous base to which client-specific nutrient recipes are added.

The system is designed to batch nutrient blends depending on the stage of the crop’s lifecycle and its feeding requirements. Batch blending is done during the ‘lights-off’ phase of the crop’s lifecycle.

This blend is then sent to standby reservoirs in each of the grow rooms, which ensures that all crops are fed in the first hour of the ‘lights-on’ cycle. Nutrients returned to the standby reservoirs after feeding are delivered to the batch tank for analysis and top-up of additional water and nutrients to meet the next feed cycle (before returning to the standby reservoirs).

The fertigation system is fully automated and works on a closed-loop basis (recovery, recycle and recirculate). GFS’s software has been developed to facilitate remote access, operation and troubleshooting the fertigation system.

RGI managing director Michael Carli spoke on the purchase order, “The Grove purchase order is the result of the remarkable efforts of our team at GFS. The sales lead for this order emanated from our booth at the recent MJ Biz Conference in Nevada in November of 2018.

“The success of the MJ Biz Conference and our register of sales leads places GFS in an excellent position for a productive and profitable year ahead,” he said.

About TGIG LLC

The Grove holds a lawful cannabis license, operating in Las Vegas, Nevada.

The purchase order involves a retro-fit and upgrade to its current operations, as it expands its cultivation facility to a second phase. The solution to be delivered by GFS will be incorporated into The Grove’s existing water treatment infrastructure, integrating a new fertigation system into custom table layouts and drains.

The GFS system will service both The Grove’s existing operations and its Phase Two expansion.



General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.

 

Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free

X